Dual-target PSMA/PSCA CAR-NK Cells in Advanced Prostate Cancer

NCT07641049 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

36

Enrollment

INDUSTRY

Sponsor class

Conditions

Metastatic Castration-resistant Prostate Cancer
Advanced Prostate Adenocarcinoma
PSCA-positive Prostate Cancer
PSMA-Positive Progressive Metastatic Castration-Resistant Prostate Cancer

Interventions

BIOLOGICAL: ETB-DualNK-01
DRUG: Fludarabine
DRUG: Cyclophosphamide

Sponsor

Beijing Biotech